We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
+36.21%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$1.28B
AUM Growth
+$134M
Cap. Flow
-$102M
Cap. Flow %
-7.96%
Top 10 Hldgs %
51.02%
Holding
98
New
23
Increased
17
Reduced
22
Closed
15

Top Buys

1
ALR
Alere Inc
ALR
+$19.9M
2
NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
+$14.7M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$12M
4
ARCT icon
Arcturus Therapeutics
ARCT
+$9.78M
5
ACGN
Aceragen Inc
ACGN
+$9.6M

Top Sells

1
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$44.6M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34.2M
3
AMAG
AMAG Pharmaceuticals
AMAG
+$24.4M
4
ASRT
Assertio
ASRT
+$20.7M
5
KND
Kindred Healthcare
KND
+$20.2M

Sector Composition

1 Healthcare 91.84%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALBO
76
DELISTED
Albireo Pharma Inc
ALBO
$1.58M 0.12%
44,334
– –
SSKN
77
DELISTED
Strata Skin Sciences
SSKN
$1.51M 0.12%
+11,758
New +$1.16M
AEGR
78
CALL
DELISTED
Aegerion Pharmaceuticals
AEGR
$1.31M 0.1%
50,000
-100,000
-67% -$2.54M
TNDM icon
79
Tandem Diabetes Care
TNDM
$1.17B
$1.29M 0.1%
+10,196
New +$1.33M
ADYX
80
DELISTED
Adynxx Inc
ADYX
$1.15M 0.09%
3,678
-15,837
-81% -$5.16M
PHIO icon
81
Phio Pharmaceuticals
PHIO
$12M
$811K 0.06%
2
– –
FATE icon
82
Fate Therapeutics
FATE
$324M
$344K 0.03%
+70,428
New +$349K
OSUR icon
83
OraSure Technologies
OSUR
$266M
$327K 0.03%
+50,000
New +$415K
AKTX
84
Akari Therapeutics
AKTX
$19.3M
– –
-59
Closed -$2.26M
LGND icon
85
Ligand Pharmaceuticals
LGND
$6.08B
– –
-318,997
Closed -$10.6M
MASI
86
DELISTED
Masimo
MASI
– –
-97,900
Closed -$2.58M
XNCR icon
87
Xencor
XNCR
$1.3B
– –
-520,881
Closed -$8.36M
INFI
88
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-450,000
Closed -$7.6M
AMAG
89
DELISTED
AMAG Pharmaceuticals
AMAG
– –
-573,530
Closed -$24.4M
KND
90
DELISTED
Kindred Healthcare
KND
– –
-1,110,300
Closed -$20.2M
CEMP
91
DELISTED
Cempra, Inc.
CEMP
– –
-284,625
Closed -$6.69M
HTWR
92
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-50,000
Closed -$3.67M
THOR
93
DELISTED
THORATEC CORPORATION
THOR
– –
-500,000
Closed -$16.2M
ASPX
94
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
– –
-100,000
Closed -$5.25M
SLXP
95
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-100,000
Closed -$11.5M
VOLC
96
DELISTED
VOLCANO CORPORATION COM STK
VOLC
– –
-2,494,854
Closed -$44.6M
AFAM
97
DELISTED
Almost Family Inc
AFAM
– –
-128,841
Closed -$3.73M
RPTP
98
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
– –
-15,558
Closed -$164K
1 2 3
4

Similar funds

CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Broadfin Capital held 98 positions worth $1.28B, up 12% from $1.15B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Broadfin Capital withdrew a net $102M in Q1 2015, closing 15 positions and reducing 22 holdings. Its most notable exit was VOLCANO CORPORATION COM STK, an estimated $44.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 83% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Broadfin Capital opened a new position in Alere Inc worth $22.1M.

  • Broadfin Capital's largest Q1 2015 buy was Alere Inc: 452,423 shares worth $22.1M.
  • Broadfin Capital added most to Aceragen Inc in Q1 2015, an estimated $9.6M increase.
  • Broadfin Capital's biggest Q1 2015 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $34.2M.
  • Broadfin Capital fully exited VOLCANO CORPORATION COM STK in Q1 2015, selling an estimated $44.6M.
  • Broadfin Capital's ten largest holdings make up 51% of its $1.28B portfolio in Q1 2015.
  • Broadfin Capital opened 23 new positions and closed 15 in Q1 2015.
  • Broadfin Capital's portfolio value rose 12% quarter-over-quarter to $1.28B.

Based on Broadfin Capital's 13F filing for Q1 2015, filed 15 May 2015.